Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03039439 · ClinicalTrials.gov registry record

Molecular and Immunohistochemical Profiling of Tumors in Patients With Parathyroid Tumors

A clinical trial of Primary Hyperparathyroidism and Parathyroid Gland Adenoma, sponsored by M.D. Anderson Cancer Center.

Recruiting
Registry status
310
Enrollment target
1
Study location

NCT03039439 is a study of Primary Hyperparathyroidism and Parathyroid Gland Adenoma that is actively recruiting participants, run by M.D. Anderson Cancer Center. The registered enrollment target is 310 participants, below the 708-participant average among 7 other Primary Hyperparathyroidism trials with a reported enrollment target (56% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03039439, a study of Primary Hyperparathyroidism and Parathyroid Gland Adenoma, is actively recruiting participants, sponsored by M.D. Anderson Cancer Center.

RECRUITING
Registry status
310 participants
Enrollment target
1
Study location

Study Summary

This trial studies molecular and immunohistochemical profiling of tumors in patients with parathyroid tumors. Studying molecular and immunohistochemical profiling of tumors may help doctors avoid inconsistencies in diagnosis, unnecessary or incomplete surgery, surgical morbidity, psychological stress, and inadequate follow up.

Conditions Studied

Primary Hyperparathyroidism Parathyroid Gland Adenoma Parathyroid Gland Atypical Adenoma Parathyroid Gland Carcinoma

Interventions

  • PROCEDURE Biospecimen Collection
  • OTHER Laboratory Biomarker Analysis

Study Locations (1)

Texas

  • M D Anderson Cancer Center - Houston

Trial Details

FieldValue
Enrollment Target 310 participants
Start Date 2015-11-24
Est. Completion 2028-11-30

Sponsor

M.D. Anderson Cancer Center

2,692 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT03039439

The ClinicalTrials.gov registry entry for NCT03039439 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 310 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 708-participant average among 7 other Primary Hyperparathyroidism trials with a reported enrollment target (56% lower). The listed sponsor is M.D. Anderson Cancer Center, which has 2,692 total studies on file at ClinicalTrials.gov.

The record links to 4 conditions, with Primary Hyperparathyroidism appearing as the primary indexed condition, and to 2 interventions - of which Biospecimen Collection is the first listed.

NCT03039439 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.

Frequently Asked Questions

What is clinical trial NCT03039439 about?

NCT03039439 is a clinical study titled "Molecular and Immunohistochemical Profiling of Tumors in Patients With Parathyroid Tumors". This trial studies molecular and immunohistochemical profiling of tumors in patients with parathyroid tumors. Studying molecular and immunohistochemical profiling of tumors may help doctors avoid inconsistencies in diagnosis, unnecessary or incomplete surgery, surgical morbidity, psychological stres...

What is the current status of trial NCT03039439?

This trial is currently recruiting. The enrollment target is 310 participants. The study started on 2015-11-24. Estimated completion is 2028-11-30.

What conditions does trial NCT03039439 study?

This clinical trial studies the following conditions: Primary Hyperparathyroidism, Parathyroid Gland Adenoma, Parathyroid Gland Atypical Adenoma, Parathyroid Gland Carcinoma.

What interventions are being tested in trial NCT03039439?

The interventions under investigation include: Biospecimen Collection (PROCEDURE), Laboratory Biomarker Analysis (OTHER).

Who is sponsoring clinical trial NCT03039439?

This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03039439 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Primary Hyperparathyroidism

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Primary Hyperparathyroidism

All registered trials for this condition

Parathyroid Gland Adenoma

All registered trials for this condition

Texas

All trials with a study site in Texas

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.